ASRT
Price
$0.80
Change
-$0.01 (-1.23%)
Updated
Sep 5 closing price
Capitalization
76.78M
61 days until earnings call
INDV
Price
$24.98
Change
+$0.25 (+1.01%)
Updated
Sep 5 closing price
Capitalization
3.09B
47 days until earnings call
Interact to see
Advertisement

ASRT vs INDV

Header iconASRT vs INDV Comparison
Open Charts ASRT vs INDVBanner chart's image
Assertio Holdings
Price$0.80
Change-$0.01 (-1.23%)
Volume$57.03K
Capitalization76.78M
Indivior
Price$24.98
Change+$0.25 (+1.01%)
Volume$3.44M
Capitalization3.09B
ASRT vs INDV Comparison Chart in %
Loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASRT vs. INDV commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a Hold and INDV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ASRT: $0.80 vs. INDV: $24.98)
Brand notoriety: ASRT and INDV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ASRT: 24% vs. INDV: 57%
Market capitalization -- ASRT: $76.78M vs. INDV: $3.09B
ASRT [@Pharmaceuticals: Generic] is valued at $76.78M. INDV’s [@Pharmaceuticals: Generic] market capitalization is $3.09B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, INDV is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 4 TA indicator(s) are bullish while INDV’s TA Score has 2 bullish TA indicator(s).

  • ASRT’s TA Score: 4 bullish, 4 bearish.
  • INDV’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, ASRT is a better buy in the short-term than INDV.

Price Growth

ASRT (@Pharmaceuticals: Generic) experienced а -4.47% price change this week, while INDV (@Pharmaceuticals: Generic) price change was +2.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ASRT is expected to report earnings on Nov 06, 2025.

INDV is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($3.09B) has a higher market cap than ASRT($76.8M). INDV YTD gains are higher at: 100.965 vs. ASRT (-8.415). INDV has higher annual earnings (EBITDA): 261M vs. ASRT (-8.66M). INDV has more cash in the bank: 510M vs. ASRT (98.2M). ASRT has less debt than INDV: ASRT (39.9M) vs INDV (366M). INDV has higher revenues than ASRT: INDV (1.17B) vs ASRT (117M).
ASRTINDVASRT / INDV
Capitalization76.8M3.09B2%
EBITDA-8.66M261M-3%
Gain YTD-8.415100.965-8%
P/E RatioN/A30.84-
Revenue117M1.17B10%
Total Cash98.2M510M19%
Total Debt39.9M366M11%
FUNDAMENTALS RATINGS
ASRT vs INDV: Fundamental Ratings
ASRT
INDV
OUTLOOK RATING
1..100
6486
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
10047
SMR RATING
1..100
9762
PRICE GROWTH RATING
1..100
5235
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
1985

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASRT's Valuation (67) in the Pharmaceuticals Major industry is in the same range as INDV (94) in the null industry. This means that ASRT’s stock grew similarly to INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (47) in the null industry is somewhat better than the same rating for ASRT (100) in the Pharmaceuticals Major industry. This means that INDV’s stock grew somewhat faster than ASRT’s over the last 12 months.

INDV's SMR Rating (62) in the null industry is somewhat better than the same rating for ASRT (97) in the Pharmaceuticals Major industry. This means that INDV’s stock grew somewhat faster than ASRT’s over the last 12 months.

INDV's Price Growth Rating (35) in the null industry is in the same range as ASRT (52) in the Pharmaceuticals Major industry. This means that INDV’s stock grew similarly to ASRT’s over the last 12 months.

ASRT's P/E Growth Rating (99) in the Pharmaceuticals Major industry is in the same range as INDV (100) in the null industry. This means that ASRT’s stock grew similarly to INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTINDV
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 1 day ago
73%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 10 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLTZY9.030.25
+2.85%
Tele2 AB
CFNCF146.65N/A
N/A
Cie Financiere Tradition Lausanne ACT
JWCTF0.66N/A
N/A
JW CAYMAN THERAPEUTICS CO LTD.
ZDZT1.92N/A
N/A
Zhengduozhe Technology, Inc
FHYDF0.36N/A
-1.05%
First Hydrogen Corp.

ASRT and

Correlation & Price change

A.I.dvisor tells us that ASRT and SNOA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASRT and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
-1.19%
SNOA - ASRT
28%
Poorly correlated
+4.42%
COLL - ASRT
26%
Poorly correlated
-2.32%
INDV - ASRT
26%
Poorly correlated
+1.01%
CPHI - ASRT
25%
Poorly correlated
+16.32%
LFCR - ASRT
24%
Poorly correlated
-5.16%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and CAIHF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and CAIHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+1.01%
CAIHF - INDV
27%
Poorly correlated
N/A
ASRT - INDV
26%
Poorly correlated
-1.19%
ALKS - INDV
25%
Poorly correlated
+3.53%
MKKGY - INDV
24%
Poorly correlated
+1.66%
HROW - INDV
24%
Poorly correlated
+2.18%
More